Hélene Schlecht

537 total citations
27 papers, 199 citations indexed

About

Hélene Schlecht is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Hélene Schlecht has authored 27 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Hélene Schlecht's work include BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (8 papers) and PARP inhibition in cancer therapy (7 papers). Hélene Schlecht is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (8 papers) and PARP inhibition in cancer therapy (7 papers). Hélene Schlecht collaborates with scholars based in United Kingdom, Italy and United States. Hélene Schlecht's co-authors include Alastair S. H. Goldman, Michael Lichten, George J. Burghel, D. Gareth Evans, Emma R. Woodward, Andrew J. Wallace, Robert D. Morgan, Michael Bulman, Fiona Lalloo and Andrew F. James and has published in prestigious journals such as Cancer Research, Genetics and Clinical Cancer Research.

In The Last Decade

Hélene Schlecht

26 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélene Schlecht United Kingdom 7 100 69 60 28 27 27 199
Estela Carrasco Spain 8 158 1.6× 105 1.5× 42 0.7× 49 1.8× 43 1.6× 20 251
Anita Collavoli Italy 9 155 1.6× 103 1.5× 21 0.3× 25 0.9× 19 0.7× 14 252
Ana Blatnik Slovenia 7 142 1.4× 57 0.8× 22 0.4× 26 0.9× 29 1.1× 29 208
Alfonso Hisado-Oliva Spain 7 140 1.4× 160 2.3× 16 0.3× 21 0.8× 21 0.8× 7 247
Bryce A. Seifert United States 7 90 0.9× 140 2.0× 40 0.7× 82 2.9× 67 2.5× 15 229
Ingrid Petroni Ewald Brazil 8 149 1.5× 164 2.4× 109 1.8× 79 2.8× 31 1.1× 12 288
Helmuth-Guenther Doerr Germany 6 221 2.2× 78 1.1× 39 0.7× 6 0.2× 10 0.4× 8 291
S.J. Xu China 7 226 2.3× 58 0.8× 22 0.4× 15 0.5× 10 0.4× 10 284
Shun‐Ping Chang Taiwan 10 96 1.0× 94 1.4× 44 0.7× 16 0.6× 5 0.2× 41 278
Loreall Pooler United States 8 87 0.9× 80 1.2× 41 0.7× 39 1.4× 13 0.5× 13 207

Countries citing papers authored by Hélene Schlecht

Since Specialization
Citations

This map shows the geographic impact of Hélene Schlecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélene Schlecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélene Schlecht more than expected).

Fields of papers citing papers by Hélene Schlecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélene Schlecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélene Schlecht. The network helps show where Hélene Schlecht may publish in the future.

Co-authorship network of co-authors of Hélene Schlecht

This figure shows the co-authorship network connecting the top 25 collaborators of Hélene Schlecht. A scholar is included among the top collaborators of Hélene Schlecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélene Schlecht. Hélene Schlecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, D. Gareth, George J. Burghel, Hélene Schlecht, et al.. (2025). UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first results. PubMed. 4(1). e000592–e000592. 1 indexed citations
2.
Kershaw, Christopher J., Leigh Demain, George J. Burghel, et al.. (2025). Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma. Clinical Genetics. 107(6). 702–704.
3.
Morgan, Robert D., Xin Wang, Jurjees Hasan, et al.. (2024). Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer. British Journal of Cancer. 131(12). 1919–1927. 5 indexed citations
4.
Chisholm, Julia, Joanna Selfe, Rita Alaggio, et al.. (2024). Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults. Pediatric Blood & Cancer. 72(1). e31428–e31428. 3 indexed citations
5.
Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2024). Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in Medicine. 26(10). 101230–101230. 5 indexed citations
6.
Evans, D. Gareth, Kate Green, George J. Burghel, et al.. (2024). Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre. Familial Cancer. 23(2). 187–195. 2 indexed citations
7.
Lindsay, Colin R., Pantelis Nicola, Andreas Gruber, et al.. (2023). Abstract 6463: Persistence of smoking mutational signatures in the non-small cell lung cancer genome. Cancer Research. 83(7_Supplement). 6463–6463. 1 indexed citations
8.
Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2023). Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?. Cancers. 15(3). 730–730. 2 indexed citations
9.
Evans, D. Gareth, George J. Burghel, Hélene Schlecht, et al.. (2023). Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer. Journal of Medical Genetics. 60(10). 974–979. 4 indexed citations
10.
Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2023). Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer. Cancers. 16(1). 177–177. 2 indexed citations
11.
Crosbie, Emma J., Richard J. Edmondson, Emma R. Woodward, et al.. (2022). High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer. Genetics in Medicine. 24(12). 2578–2586. 2 indexed citations
12.
Evans, D. Gareth, Elke M. van Veen, George J. Burghel, et al.. (2022). Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers. Journal of Medical Genetics. 60(8). 740–746. 2 indexed citations
13.
Morgan, Robert D., George J. Burghel, Michael Bulman, et al.. (2022). Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer. Journal of Clinical Pathology. 76(10). 684–689. 3 indexed citations
14.
Morgan, Robert D., Louisa Nelson, Anthony Tighe, et al.. (2021). Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models. Journal of Experimental & Clinical Cancer Research. 40(1). 323–323. 26 indexed citations
15.
Alexander, Elizabeth, Naomi L. Bowers, Andrew J. Wallace, et al.. (2021). Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives. European Journal of Human Genetics. 29(5). 861–871. 3 indexed citations
16.
Berland, Siren, et al.. (2021). The blended phenotype of a germline RIT1 and a mosaic PIK3CA variant. Molecular Case Studies. 7(6). a006121–a006121. 3 indexed citations
17.
Murphy, Peter J., Sofia Dias, Lindsay Claxton, et al.. (2021). Appraising the Costs of Genomic Testing for Histology-Independent Technologies: An Illustrative Example for NTRK Fusions. Value in Health. 25(7). 1133–1140. 4 indexed citations
18.
Nicola, Pantelis, Shereen Rafee, George J. Burghel, et al.. (2020). Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome. Cancer Research. 80(16_Supplement). 3810–3810. 1 indexed citations
19.
Tobi, Simon, et al.. (2008). Incidence of Classical 21-Hydroxylase Deficiency and Distribution of <i>CYP21A2</i> Mutations in Estonia. Hormone Research in Paediatrics. 69(4). 227–232. 5 indexed citations
20.
Boon, Elles M. J., Hélene Schlecht, Peter Martin, et al.. (2007). Y chromosome detection by Real Time PCR and pyrophosphorolysis‐activated polymerisation using free fetal DNA isolated from maternal plasma. Prenatal Diagnosis. 27(10). 932–937. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Estela Carrasco Breakdown of academic impact, for papers by Anita Collavoli Breakdown of academic impact, for papers by Ana Blatnik Breakdown of academic impact, for papers by Alfonso Hisado-Oliva Breakdown of academic impact, for papers by Bryce A. Seifert Breakdown of academic impact, for papers by Ingrid Petroni Ewald Breakdown of academic impact, for papers by Helmuth-Guenther Doerr Breakdown of academic impact, for papers by S.J. Xu Breakdown of academic impact, for papers by Shun‐Ping Chang Breakdown of academic impact, for papers by Loreall Pooler
Rankless by CCL
2026